![Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study - ScienceDirect Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0015028213030604-gr1.jpg)
Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study - ScienceDirect
![PDF) Comparison of the Efficacy of Two Vaginal Progesterone Formulations, Crinone 8% Gel and Utrogestan Capsules, Used for Luteal Support in Blastocyst Stage Embryo Transfers PDF) Comparison of the Efficacy of Two Vaginal Progesterone Formulations, Crinone 8% Gel and Utrogestan Capsules, Used for Luteal Support in Blastocyst Stage Embryo Transfers](https://i1.rgstatic.net/publication/40833855_Comparison_of_the_Efficacy_of_Two_Vaginal_Progesterone_Formulations_Crinone_8_Gel_and_Utrogestan_Capsules_Used_for_Luteal_Support_in_Blastocyst_Stage_Embryo_Transfers/links/54c8db300cf289f0ced10072/largepreview.png)
PDF) Comparison of the Efficacy of Two Vaginal Progesterone Formulations, Crinone 8% Gel and Utrogestan Capsules, Used for Luteal Support in Blastocyst Stage Embryo Transfers
![Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women - ScienceDirect Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0015028299005531-gr1.gif)
Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women - ScienceDirect
![Crinone 8% (90 mg) given once daily for progesterone replacement therapy in donor egg cycles - ScienceDirect Crinone 8% (90 mg) given once daily for progesterone replacement therapy in donor egg cycles - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0015028299003908-gr1.gif)